Numerous clinical trials evaluate betamethasone across Phase 1 to Phase 4 studies and non-interventional protocols for varied indications. Key research areas focus on maternal-fetal health (antenatal lung maturation, in utero myelomeningocele repair), dermatological conditions (psoriasis, allergic rhinitis, paronychia), pain disorders (spinal and low back pain, shoulder osteoarthritis), and endocrine diseases such as Addison disease. Sponsored by diverse academic medical centers and industry partners, these studies encompass various recruitment statuses, including actively recruiting and completed.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07416916 | RECRUITING | Frozen Shoulder |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2026-02-23 | PHASE4 |
| NCT07448285 | RECRUITING | Chronic Pain |
Biobizkaia Health Research Institute |
2026-02-24 | PHASE3 |
| NCT06527235 | RECRUITING | Meniscus Lesion |
University Hospital, Toulouse |
2025-03-06 | PHASE3 |
| NCT07453004 | RECRUITING | Acute Gouty Arthritis |
TJ Biopharma Co., Ltd. |
2026-03-26 | PHASE2 |
| NCT07508124 | RECRUITING | Urinary Tract Infection |
Baylor College of Medicine |
2026-05-08 | PHASE4 |
| NCT07348016 | RECRUITING | Rotator Cuff Injuries; Adhesions |
Second Affiliated Hospital of Nanchang University |
2025-08-01 | |
| NCT07668895 | NOT_YET_RECRUITING | Sarcoidosis, Pulmonary |
Peking Union Medical College Hospital |
2026-07 | PHASE2; PHASE3 |
| NCT07366268 | NOT_YET_RECRUITING | Psoriasis |
Assiut University |
2026-05 | |
| NCT07681804 | RECRUITING | Trigger Finger |
Istanbul University - Cerrahpasa |
2026-06-30 | |
| NCT07447739 | NOT_YET_RECRUITING | Respiratory Distress Syndrome (RDS); Bronchopulmonary Dysplasia (BPD) |
Khang Nguyen |
2026-04 | PHASE2 |
| NCT05535738 | ACTIVE_NOT_RECRUITING | Skin Inflammation; Allergic Contact Dermatitis |
Wei-Che Ko |
2022-11-15 | PHASE2; PHASE3 |
| NCT05981118 | ENROLLING_BY_INVITATION | ICD10 Code L40.9 for Psoriasis |
Wake Forest University Health Sciences |
2024-07-15 | PHASE2; PHASE3 |
| NCT07713186 | NOT_YET_RECRUITING | Atopic Dermatitis |
Cairo University |
2026-08-01 | PHASE4 |
| NCT06863701 | RECRUITING | Gout Arthritis; Gout Attack |
Laboratorios Silanes S.A. de C.V. |
2025-01-27 | PHASE3 |
| NCT07683650 | RECRUITING | TMJ Disc Displacement With Reduction |
Mansoura University |
2026-01-06 | |
| NCT07547605 | RECRUITING | Myofascial Pain Dysfunction Syndrome; Trigger Points, Myofascial; Trigger Point in Trapezius Muscle |
University of Kyrenia |
2026-05-15 | PHASE4 |
| NCT07409779 | NOT_YET_RECRUITING | Adhesive Capsulitis of the Shoulder |
Faculty of Medicine of Tunis |
2026-04-01 | |
| NCT07635043 | NOT_YET_RECRUITING | Psoriasis (PsO) |
Pakistan Institute of Medical Sciences |
2026-08-01 | PHASE4 |
| NCT07696585 | NOT_YET_RECRUITING | Alopecia Areata |
Sohag University |
2026-06-28 | |
| NCT06915857 | RECRUITING | Breast Cancer; Radiation Dermatitis |
Sunnybrook Health Sciences Centre |
2025-02-26 | PHASE3 |
| NCT06854380 | RECRUITING | Voice and Voice Disorders |
Mansoura University |
2026-01-01 | EARLY_PHASE1 |
| NCT07105540 | COMPLETED | Carpal Tunnel Syndrome |
Ankara Etlik City Hospital |
2025-08-05 | PHASE4 |
| NCT07267273 | RECRUITING | Vitiligo |
Cairo University |
2025-11-10 | |
| NCT06643416 | RECRUITING | Paronychia; EGFR-TKI; ALK-TKI |
Queen Mary Hospital, Hong Kong |
2024-10-09 | PHASE3 |
| NCT07000409 | RECRUITING | Postherpetic Neuralgia; Chronic Pain; Ultrasound Guidance; Erector Spinae Plane Block; Betamethasone |
Cairo University |
2025-05-01 | |
| NCT07256834 | NOT_YET_RECRUITING | Post Operative Sore Throat at 6hrs and 24hrs After Endotracheal Intubation |
Jinnah Postgraduate Medical Centre |
2025-11-22 | PHASE1; PHASE2 |
| NCT07131657 | COMPLETED | Nerve Block; Upper Extremity Surgery |
PHARMAFINA |
2025-09-02 | PHASE2 |
| NCT07113756 | NOT_YET_RECRUITING | Plaque Psoriasis |
Sohag University |
2025-09-01 | |
| NCT07242846 | COMPLETED | Knee Osteoarthritis (Knee OA); Intraocular Pressure |
Nigde Omer Halisdemir University |
2025-10-02 | PHASE4 |
| NCT04021485 | RECRUITING | Premature Childbirth |
Assistance Publique - Hôpitaux de Paris |
2022-03-23 | |
| NCT06916884 | COMPLETED | Allergic Rhinitis |
Laboratorios Silanes S.A. de C.V. |
2024-11-11 | PHASE3 |
| NCT07078786 | RECRUITING | Cardiotocography; Steroids |
Rawalpindi Medical College |
2025-07-13 | PHASE4 |
| NCT06599086 | RECRUITING | Carpal Tunnel Syndrome |
Yunus Burak Bayır |
2024-09-15 | |
| NCT06785350 | RECRUITING | Pain Management; Spine Surgery |
Beijing Tiantan Hospital |
2025-01-25 | |
| NCT06626568 | COMPLETED | Frozen Shoulder |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2024-10-15 | PHASE2 |
| NCT07328022 | COMPLETED | Bursitis; Tendinitis; Synovitis |
Laboratorios Silanes S.A. de C.V. |
2025-05-14 | PHASE3 |
| NCT03783182 | UNKNOWN | Tonsillectomy; Pain; PONV; Bleeding |
Umeå University |
2019-09-10 | PHASE4 |
| NCT05882903 | RECRUITING | Chronic Rhinosinusitis (Diagnosis) |
Oticara Australia PTY LTD |
2023-08-17 | PHASE2 |
| NCT06785935 | ACTIVE_NOT_RECRUITING | Trigger Finger |
Mansoura University Hospital |
2024-11-11 | |
| NCT06781632 | COMPLETED | Healthy; Nerve Block |
PHARMAFINA |
2024-11-13 | PHASE1 |
| NCT06299813 | UNKNOWN | Adenovirus |
A.O.U. Città della Salute e della Scienza |
2024-03-20 | PHASE3 |
| NCT06084624 | UNKNOWN | Oral Ulceration Due to Behçet's Disease |
Cairo University |
2023-12 | PHASE1; PHASE2 |
| NCT06332612 | COMPLETED | Oral Submucous Fibrosis |
Ziauddin University |
2024-08-12 | PHASE1; PHASE2 |
| NCT06169891 | UNKNOWN | Acute Gout |
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. |
2023-12 | PHASE3 |
| NCT02604537 | COMPLETED | DeQuervain Tendinopathy |
OrthoCarolina Research Institute, Inc. |
2015-10-15 | PHASE4 |
| NCT06087796 | UNKNOWN | Alopecia Areata |
Assiut University |
2023-10 | PHASE1 |
| NCT05926895 | COMPLETED | Central Sensitisation; Subacromial Impingement Syndrome |
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey |
2023-06-02 | |
| NCT06267066 | UNKNOWN | Lichen Simplex Chronicus |
Cairo University |
2024-03-01 | |
| NCT05139875 | COMPLETED | Knee Osteoarthritis |
Thammasat University |
2022-01-01 | PHASE4 |
| NCT07156513 | COMPLETED | Persistent Spinal Pain Syndrome Type II; Failed Back Surgery Syndrome; Chronic Low Back Pain; Post-Laminectomy Syndrome |
Puerta de Hierro University Hospital |
2021-01-02 | |
| NCT03474991 | COMPLETED | Community-acquired Pneumonia |
Julia Bielicki |
2018-10-28 | PHASE3 |
| NCT05285943 | COMPLETED | Radiodermatitis; Acute |
Cairo University |
2021-11-04 | PHASE4 |
| NCT05233735 | UNKNOWN | Vitiligo |
Tel-Aviv Sourasky Medical Center |
2021-01-01 | |
| NCT06140186 | UNKNOWN | Paronychia |
Queen Mary Hospital, Hong Kong |
2023-04-01 | PHASE3 |
| NCT05220293 | TERMINATED | Chronic Rhinosinusitis (Diagnosis) |
Oticara Australia PTY LTD |
2022-02-23 | PHASE1; PHASE2 |
| NCT02939742 | TERMINATED | PPROM; Respiratory Distress Syndrome in Premature Infants |
The University of Texas Medical Branch, Galveston |
2016-11 | PHASE2; PHASE3 |
| NCT07710651 | COMPLETED | Adhesive Capsulitis; Corticosteroid Injection |
Istanbul University - Cerrahpasa |
2023-08-15 | |
| NCT06034418 | COMPLETED | Coxarthrosis; Primary |
Ankara City Hospital Bilkent |
2022-11-25 | |
| NCT04227288 | COMPLETED | Nail Psoriasis |
University of Alabama at Birmingham |
2021-11-01 | PHASE4 |
| NCT04976816 | COMPLETED | Thyroid Eye Disease |
Assiut University |
2021-12-01 | PHASE2; PHASE3 |
| NCT05555797 | UNKNOWN | Psoriasis |
Assiut University |
2022-10-30 | PHASE4 |
| NCT05588908 | UNKNOWN | Acute Gout |
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. |
2022-06-29 | PHASE1; PHASE2 |
| NCT04440371 | UNKNOWN | Vitiligo, Generalized |
Jordan University of Science and Technology |
2020-06-21 | |
| NCT04869709 | UNKNOWN | Neonatal Hypoglycemia; Prematurity |
University of Southern California |
2021-07 | PHASE4 |
| NCT06786689 | COMPLETED | Alopecia Areata; Alopecia Areata(AA) |
Sheikh Zayed Medical College |
2023-03-01 | PHASE2 |
| NCT06011083 | COMPLETED | Psoriasis Vulgaris; Fractional CO2 Laser |
Assiut University |
2022-08-01 | |
| NCT07297264 | TERMINATED | Morbidity; Third Molars Extraction; Steroid Injection |
Shehab Ahmed Hamad |
2022-01-03 | PHASE3 |
| NCT05556122 | UNKNOWN | Nerve Block |
Affiliated Hospital of Nantong University |
2022-07-04 | |
| NCT04900220 | COMPLETED | Trigger Finger |
West Virginia University |
2021-09-15 | PHASE4 |
| NCT03770546 | WITHDRAWN | Osteoarthritis of the Shoulder; Adhesive Capsulitis |
University of Alabama at Birmingham |
2021-10-30 | |
| NCT07454369 | COMPLETED | Healthy |
Laboratorios Silanes S.A. de C.V. |
2022-10-24 | PHASE1 |
| NCT05531890 | UNKNOWN | Ataxia Telangiectasia |
Grace Therapeutics Inc. |
2022-09-13 | PHASE1 |
| NCT04734210 | COMPLETED | Dry Eye Disease |
Surface Ophthalmics, Inc. |
2021-01-07 | PHASE2 |
| NCT04931511 | TERMINATED | Frozen Shoulder; Shoulder Pain; Bursitis |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2021-06-01 | PHASE4 |
| NCT02469519 | COMPLETED | Premature Birth |
Pediatrix |
2016-03-03 | PHASE2; PHASE3 |
| NCT05249972 | UNKNOWN | Mild to Moderate Psoriasis |
Lipidor AB |
2022-01-24 | PHASE3 |
| NCT05175001 | UNKNOWN | Chronic Pain |
Affiliated Hospital of Nantong University |
2021-05-01 | PHASE4 |
| NCT04734197 | COMPLETED | Dry Eye Disease |
Surface Ophthalmics, Inc. |
2021-01-11 | PHASE2 |
| NCT04153396 | COMPLETED | Pain, Postoperative; Neurosurgery |
Beijing Tiantan Hospital |
2021-09-01 | PHASE4 |
| NCT03210545 | COMPLETED | Addison Disease |
Göteborg University |
2021-03-02 | PHASE4 |
| NCT04593706 | UNKNOWN | Keloid; Hypertrophic Scar; Scars; Scarring |
Tel-Aviv Sourasky Medical Center |
2020-11-01 | |
| NCT04476420 | COMPLETED | Oral Submucous Fibrosis |
Ziauddin University |
2021-02-11 | PHASE3 |
| NCT04194814 | COMPLETED | Atopic Eczema/Dermatitis (Non-Specific) |
Sheffield Teaching Hospitals NHS Foundation Trust |
2020-11-20 | PHASE2 |
| NCT03156829 | UNKNOWN | Trigger Finger |
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
2017-11-27 | PHASE4 |
| NCT04494529 | COMPLETED | Preterm Birth; Complication of Prematurity; Obstetric Labor, Premature; Obstetric Labor Complications; Pregnancy Complications |
McMaster University |
2021-03-01 | PHASE3 |
| NCT04555707 | UNKNOWN | Psoriasis |
Derm Research, PLLC |
2020-06-24 | PHASE4 |
| NCT04420572 | COMPLETED | Trochanteric Bursitis |
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey |
2021-03-11 | |
| NCT04278833 | TERMINATED | Osteoarthritis; Tendinopathy; Impingement Shoulder |
Stanford University |
2020-09-01 | PHASE4 |
| NCT04407975 | UNKNOWN | Respiratory Morbidity |
Makassed General Hospital |
2020-05-29 | |
| NCT05058209 | COMPLETED | Osteoarthritis, Knee |
ROC Foundation |
2020-11-30 | PHASE4 |
| NCT04770805 | Recruiting | Sacral Myelomeningocele|Neural Tube Defects|Spina Bifida |
Assistance Publique - Hôpitaux de Paris |
2021-04-16 | Not Applicable |
| NCT04114097 | COMPLETED | Atopic Dermatitis; Atopic Eczema |
Jacob Thyssen |
2019-08-22 | PHASE4 |
| NCT02038634 | TERMINATED | DeQuervain's Tenosynovitis |
Medical College of Wisconsin |
2014-08-05 | PHASE4 |
| NCT02912182 | TERMINATED | Vestibular Diseases; Vestibular Neuronitis |
Lund University |
2015-12 | PHASE4 |
| NCT04372277 | RECRUITING | Psoriasis |
Psoriasis Treatment Center of Central New Jersey |
2020-04-28 | PHASE4 |
| NCT03210545 | Unknown status | Addison Disease |
Göteborg University |
2021-03-02 | Phase 4 |
| NCT04860531 | COMPLETED | Lumbar Facet Joint Syndrome |
Ain Shams University |
2019-09-17 | PHASE3 |
| NCT06264973 | Recruiting | Preterm Birth |
Erasmus Medical Center |
2021-01-01 | -- |
| NCT03766997 | UNKNOWN | Granulomatous Mastitis |
Peking Union Medical College Hospital |
2019-02-19 | PHASE4 |
| NCT04196400 | UNKNOWN | Hypospadias |
Cairo University |
2019-12-01 | EARLY_PHASE1 |
| NCT03300531 | UNKNOWN | Rotator Cuff Tear; Lateral Epicondylitis; Achilles Tendinitis |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2017-12-01 | PHASE2 |
| NCT04444726 | COMPLETED | Atopic Dermatitis |
Cairo University |
2019-01-20 | |
| NCT04306653 | UNKNOWN | Gout Attack |
University of Patras |
2018-01-05 | |
| NCT03731091 | COMPLETED | Psoriasis Vulgaris |
Glenmark Pharmaceuticals Ltd. India |
2018-10-31 | PHASE3 |
| NCT04982809 | COMPLETED | Interstitial Lung Disease |
Cairo University |
2018-07-01 | |
| NCT04221906 | COMPLETED | Chronic Plaque Psoriasis |
Boston Pharmaceuticals |
2020-01-06 | PHASE1 |
| NCT02582177 | COMPLETED | Tinea |
Ache Laboratorios Farmaceuticos S.A. |
2019-06-11 | PHASE3 |
| NCT02897076 | COMPLETED | Neonatal Complications |
Assistance Publique - Hôpitaux de Paris |
2017-01 | PHASE3 |
| NCT03279796 | UNKNOWN | Rotator Cuff Tear; Lateral Epicondylitis |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2018-10-01 | PHASE2 |
| NCT04071106 | UNKNOWN | Psoriasis |
Zagazig University |
2019-09-01 | PHASE2; PHASE3 |
| NCT03898583 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2019-04-15 | PHASE1 |
| NCT03506477 | COMPLETED | Plaque Psoriasis; Psoriasis |
Icahn School of Medicine at Mount Sinai |
2018-05-21 | PHASE4 |
| NCT03827876 | RECRUITING | Psoriasis |
Psoriasis Treatment Center of Central New Jersey |
2019-01-16 | PHASE4 |
| NCT03165825 | WITHDRAWN | Cervical Radiculopathy |
Vanderbilt University Medical Center |
2018-01 | PHASE4 |
| NCT03446937 | COMPLETED | Neonatal Respiratory Distress Syndrome |
Ahmadu Bello University Teaching Hospital |
2017-12-01 | |
| NCT03395132 | TERMINATED | Infected Atopic Dermatitis/Eczema |
LEO Pharma |
2018-07-31 | PHASE3 |
| NCT02527421 | TERMINATED | Plaque Psoriasis |
Primus Pharmaceuticals |
2015-08-19 | PHASE3 |
| NCT03469336 | COMPLETED | Psoriasis |
Pfizer |
2018-04-24 | PHASE1 |
| NCT03880357 | COMPLETED | Scalp Psoriasis |
Sun Pharmaceutical Industries, Inc. |
2018-10-22 | PHASE1 |
| NCT03668860 | COMPLETED | Preterm Birth; Antenatal Corticosteroids |
Children's Hospital Medical Center, Cincinnati |
2018-09-20 | PHASE1 |
| NCT03669757 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2018-09-27 | PHASE1 |
| NCT03707795 | COMPLETED | Familial Amyotrophic Lateral Sclerosis |
Edward Kasaraskis |
2017-08-21 | EARLY_PHASE1 |
| NCT03758365 | COMPLETED | Vasoconstriction |
MC2 Therapeutics |
2018-11-05 | PHASE1 |
| NCT03331523 | COMPLETED | Scalp Psoriasis |
Glenmark Pharmaceuticals Ltd. India |
2017-10-20 | PHASE3 |
| NCT03584360 | COMPLETED | Psoriasis Vulgaris |
Centre Hospitalier Universitaire de Nice |
2018-09-24 | PHASE2 |
| NCT03052348 | UNKNOWN | Severe Atopic Dermatitis |
Red Cross War Memorial Childrens Hospital |
2017-11-01 | |
| NCT02833116 | UNKNOWN | Chronic Pain |
Basque Health Service |
2016-06 | PHASE4 |
| NCT02978976 | UNKNOWN | Neonatal Respiratory Distress |
Kasr El Aini Hospital |
2017-01 | PHASE4 |
| NCT02686983 | UNKNOWN | Chronic Migraine |
Jakob Møller Hansen, MD. |
2016-03 | PHASE4 |
| NCT03026478 | UNKNOWN | Oral Lichen Planus |
Garlapati Komali |
2016-05-06 | PHASE2 |
| NCT03442244 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2018-01-30 | PHASE1 |
| NCT02038569 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2014-01 | PHASE2 |
| NCT03215407 | UNKNOWN | Rheumatoid Arthritis of Knee |
Chinese PLA General Hospital |
2017-08-01 | PHASE4 |
| NCT03240783 | UNKNOWN | Acute Sciatica |
St George Hospital, Australia |
2017-07-08 | PHASE2 |
| NCT03122353 | COMPLETED | Scalp Psoriasis |
Tolmar Inc. |
2017-04-11 | PHASE1 |
| NCT03080545 | COMPLETED | Psoriasis |
Psoriasis Treatment Center of Central New Jersey |
2017-05-01 | PHASE4 |
| NCT02612272 | UNKNOWN | Knee Osteoarthritis |
St. Luke's Hospital, Pennsylvania |
2015-11 | PHASE4 |
| NCT02586961 | TERMINATED | Children; Bronchiolitis |
Assistance Publique - Hôpitaux de Paris |
2015-10 | PHASE2; PHASE3 |
| NCT03196817 | UNKNOWN | Carpal Tunnel Syndrome |
Hospital Alvorada |
2016-08-01 | PHASE4 |
| NCT02858713 | COMPLETED | Adherence |
Odense University Hospital |
2017-01-09 | PHASE4 |
| NCT02940002 | COMPLETED | Psoriasis |
Bayer |
2016-10-12 | PHASE1 |
| NCT02652884 | UNKNOWN | Transient Hypoparathyroidism |
Hospital Italiano de Buenos Aires |
2016-01 | PHASE4 |
| NCT01808586 | COMPLETED | Neck Pain |
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
2013-05 | PHASE2 |
| NCT02744495 | COMPLETED | Postoperative Vomiting; Postoperative Nausea; Postoperative Emesis |
Hôpital Privé de Parly II - Le Chesnay |
2016-02 | PHASE3 |
| NCT02892500 | TERMINATED | Ankle Injuries |
Sanford Health |
2016-04 | PHASE2 |
| NCT01529242 | TERMINATED | Cutaneous Hypersensitivity |
EMS |
2014-02 | PHASE3 |
| NCT02749799 | COMPLETED | Plaque Psoriasis |
Primus Pharmaceuticals |
2016-02 | PHASE4 |
| NCT02668692 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2016-02 | PHASE3 |
| NCT02733874 | COMPLETED | Psoriasis |
First Hospital of China Medical University |
2015-04 | PHASE4 |
| NCT02548052 | COMPLETED | Psoriasis |
GlaxoSmithKline |
2015-10-22 | PHASE1 |
| NCT03101033 | COMPLETED | Herniated Lumbar Disc |
yan lu |
2015-05 | |
| NCT02351310 | WITHDRAWN | Preterm Labor; Premature Birth |
Pediatrix |
2015-11 | PHASE3 |
| NCT02376049 | COMPLETED | Atopic Dermatitis |
LEO Pharma |
2015-02 | PHASE1 |
| NCT02416258 | COMPLETED | Skin and Connective Tissue Diseases |
LEO Pharma |
2015-04 | PHASE2 |
| NCT02489643 | COMPLETED | Psoriasis |
Catholic University of the Sacred Heart |
2014-05 | |
| NCT02379793 | COMPLETED | Skin and Connective Tissue Diseases |
LEO Pharma |
2015-03 | PHASE1 |
| NCT02355639 | COMPLETED | Skin and Connective Tissue Diseases |
LEO Pharma |
2015-01 | PHASE1 |
| NCT01222247 | COMPLETED | Pregnancy; Respiratory Distress Syndrome; Pregnancy Outcomes; Preterm Birth |
The George Washington University Biostatistics Center |
2010-10 | PHASE3 |
| NCT02350023 | COMPLETED | Alopecia Areata |
Post Graduate Institute of Medical Education and Research, Chandigarh |
2014-09 | PHASE4 |
| NCT01885481 | COMPLETED | Back Pain; Neck Pain |
Seoul National University Bundang Hospital |
2013-10 | |
| NCT02132936 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2014-06 | PHASE3 |
| NCT02114073 | COMPLETED | Glaucoma, Open Angle |
Mashhad University of Medical Sciences |
2014-04 | PHASE2 |
| NCT01710384 | UNKNOWN | Late Preterm |
Meir Medical Center |
2012-11 | PHASE2 |
| NCT02261662 | UNKNOWN | Hepatitis C; Lichen Planus; Vasculitis; Autoimmune Diseases |
Tanta University |
2014-06 | |
| NCT02070965 | COMPLETED | Plaque Psoriasis |
Primus Pharmaceuticals |
2014-01 | PHASE2 |
| NCT01529229 | COMPLETED | Allergic Rhinitis |
EMS |
2013-11 | PHASE3 |
| NCT01768078 | COMPLETED | Post-operative Endophthalmitis |
Centre Hospitalier Universitaire Dijon |
2008-09 | PHASE3 |
| NCT02575729 | COMPLETED | Carpal Tunnel Syndrome(CTS) |
Chang Gung Memorial Hospital |
2011-08 | PHASE3 |
| NCT02004574 | COMPLETED | Psoriasis Vulgaris |
Jooheung Lee |
2013-10 | PHASE4 |
| NCT02148016 | UNKNOWN | Corneal Disease; Pterygium; Myopia; Hyperopia |
Sun Yat-sen University |
2012-12 | PHASE1; PHASE2 |
| NCT02191007 | COMPLETED | Psoriasis |
Xijing Hospital |
2013-11 | |
| NCT01720485 | UNKNOWN | Allergic Rhinitis |
EMS |
2013-10 | PHASE3 |
| NCT02920658 | COMPLETED | Oral Lichen Planus; Recurrent Aphthous Stomatitis |
Ivan Alajbeg |
2010-12 | PHASE2 |
| NCT00446953 | COMPLETED | Neonatal Distress |
University Hospital, Strasbourg, France |
2007-02 | PHASE4 |
| NCT01946386 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2013-09 | PHASE1 |
| NCT02432040 | COMPLETED | Psoriasis |
Philippine Dermatological Society |
2013-02 | PHASE2 |
| NCT01206946 | UNKNOWN | Respiratory Distress Syndrome, Newborn; Transient Tachypnea of the Newborn |
American University of Beirut Medical Center |
2010-09 | PHASE2 |
| NCT01837576 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2013-04 | PHASE1 |
| NCT03399526 | COMPLETED | Psoriasis |
Bayer |
2013-02-11 | PHASE1 |
| NCT02114021 | COMPLETED | Sore Throat; Cough |
Tehran University of Medical Sciences |
2012-03 | PHASE3 |
| NCT01646567 | COMPLETED | Plaque Type Psoriasis |
TetraLogic Pharmaceuticals |
2012-09 | PHASE1 |
| NCT01061853 | TERMINATED | Oral Lichen Planus |
University Hospital, Tours |
2008-02 | PHASE3 |
| NCT01768013 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2012-07 | PHASE1; PHASE2 |
| NCT01536886 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2012-05 | PHASE2 |
| NCT01536938 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2012-05 | PHASE2 |
| NCT01120223 | COMPLETED | Scalp Psoriasis |
LEO Pharma |
2010-05 | PHASE2 |
| NCT01083758 | COMPLETED | Scalp Psoriasis |
LEO Pharma |
2010-04 | PHASE2 |
| NCT02443311 | COMPLETED | Oral Lichen Planus |
Ain Shams University |
2010-09 | PHASE4 |
| NCT01429701 | COMPLETED | Eczema |
EMS |
2012-05 | PHASE3 |
| NCT01422434 | COMPLETED | Psoriasis |
LEO Pharma |
2011-07 | PHASE3 |
| NCT01413477 | UNKNOWN | Allergic Contact Dermatitis |
University of British Columbia |
2011-08 | |
| NCT01011621 | UNKNOWN | Dermatitis, Atopic; Dermatitis, Contact; Dermatitis, Seborrheic; Psoriasis |
Mantecorp Industria Quimica e Farmaceutica Ltd. |
2010-02 | PHASE3 |
| NCT00817219 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2009-07 | PHASE2 |
| NCT00982332 | UNKNOWN | Polymyalgia Rheumatica |
Bnai Zion Medical Center |
2010-03 | |
| NCT01229098 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2010-10 | PHASE2 |
| NCT00670956 | TERMINATED | Congenital Cystic Adenomatoid Malformation |
University of California, San Francisco |
2008-04 | PHASE1; PHASE2 |
| NCT01033097 | COMPLETED | Pruritus in Patients With Atopic Dermatitis |
Novartis Pharmaceuticals |
2009-11 | PHASE2 |
| NCT01347255 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2011-05 | PHASE2 |
| NCT01188928 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2010-09 | PHASE3 |
| NCT00685880 | TERMINATED | Thumb Carpometacarpal Joint Osteoarthritis |
Mayo Clinic |
2008-05 | |
| NCT00675246 | COMPLETED | Hyaline Membrane Disease; Transient Tachypnea |
Instituto Materno Infantil Prof. Fernando Figueira |
2008-05 | |
| NCT00671528 | TERMINATED | Dermatitis, Atopic; Eczema, Atopic; Skin Diseases, Eczematous |
Organon and Co |
2009-07 | PHASE4 |
| NCT00914836 | WITHDRAWN | Tendonitis; Bursitis |
HaEmek Medical Center, Israel |
2009-06 | |
| NCT00987870 | COMPLETED | Psoriasis; Arthritis |
Novartis Pharmaceuticals |
2009-09 | PHASE1; PHASE2 |
| NCT00453141 | COMPLETED | Preterm Delivery |
The Cooper Health System |
2006-04 | |
| NCT00933023 | WITHDRAWN | Phimosis |
Chelsea and Westminster NHS Foundation Trust |
2009-08 | PHASE4 |
| NCT00623766 | COMPLETED | Melanoma |
Bristol-Myers Squibb |
2008-07 | PHASE2 |
| NCT00875277 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2009-04 | PHASE2 |
| NCT00670241 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2008-04 | PHASE3 |
| NCT00608777 | TERMINATED | Plaque Psoriasis |
Derm Research, PLLC |
2008-01 | PHASE4 |
| NCT00820950 | COMPLETED | Psoriasis |
Incyte Corporation |
2007-05-31 | PHASE2 |
| NCT00542139 | COMPLETED | Osteoarthritis |
Hadassah Medical Organization |
2007-12 | PHASE4 |
| NCT00574249 | COMPLETED | Chronic Plaque Psoriasis |
Abbott |
2007-11 | PHASE3 |
| NCT00578370 | COMPLETED | Psoriasis |
ISDIN |
2007-11 | PHASE1; PHASE2 |
| NCT00201643 | COMPLETED | Preterm Delivery |
Obstetrix Medical Group |
2003-11 | PHASE4 |
| NCT00669383 | COMPLETED | Respiratory Compliance; Functional Residual Capacity; Pulmonary Function Testing |
Oregon Health and Science University |
2001-06 | |
| NCT00608673 | COMPLETED | Discoid Lupus Erythematosus |
Shahid Beheshti University of Medical Sciences |
2006-04 | |
| NCT00437255 | COMPLETED | Plaque Psoriasis |
Galderma R&D |
2006-08 | PHASE4 |
| NCT00139256 | TERMINATED | Respiratory Distress Syndrome, Newborn |
Emory University |
2005-08 | PHASE2; PHASE3 |
| NCT00963573 | COMPLETED | Rhinitis |
Merck Sharp & Dohme LLC |
2003-09 | PHASE4 |
| NCT00015002 | TERMINATED | Complications, Pregnancy |
The George Washington University Biostatistics Center |
2000-03 | PHASE3 |
| NCT00358384 | COMPLETED | Psoriasis |
GlaxoSmithKline |
2005-09-26 | PHASE1 |
| NCT02865746 | COMPLETED | Pain |
Federal University of the Valleys of Jequitinhonha and Mucuri |
2004-07 | |
| NCT00216892 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2005-04 | PHASE4 |
| NCT00216840 | COMPLETED | Psoriasis of Scalp |
LEO Pharma |
2004-12 | PHASE3 |
| NCT00243464 | COMPLETED | Psoriasis of Scalp |
LEO Pharma |
2005-09 | PHASE3 |
| NCT01411254 | COMPLETED | Diabetic Macular Edema |
Santen Pharmaceutical Co., Ltd. |
PHASE2; PHASE3 | |
| NCT00004778 | COMPLETED | Respiratory Distress Syndrome |
National Center for Research Resources (NCRR) |
1993-08 | PHASE3 |
| NCT00248456 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2005-10 | PHASE4 |
| NCT00263718 | COMPLETED | Psoriasis Vulgaris |
LEO Pharma |
2005-12 | PHASE2 |
| NCT00418353 | COMPLETED | Respiratory Distress Syndrome; Intraventricular Hemorrhage; Neonatal Mortality |
University of Oklahoma |
2002-08 | |
| NCT00216827 | COMPLETED | Psoriasis of Scalp |
LEO Pharma |
2004-11 | PHASE3 |
| NCT00576550 | COMPLETED | Hand Eczema |
ACO Hud Nordic AB |
2007-10 | PHASE4 |
| NCT00279162 | COMPLETED | Psoriasis |
LEO Pharma |
2005-12 | PHASE3 |
| NCT00295464 | TERMINATED | Respiratory Distress Syndrome; Intraventricular Haemorrhage |
University of Oulu |
2001-05 | PHASE4 |
| NCT00216879 | COMPLETED | Psoriasis of Scalp |
LEO Pharma |
2005-02 | PHASE3 |
| NCT00209859 | COMPLETED | Rheumatoid Arthritis |
Hvidovre University Hospital |
1998-10 | PHASE4 |
| NCT01132079 | COMPLETED | Atopic Dermatitis |
University of Kiel |
2005-03 | |
| NCT01512901 | COMPLETED | Macular Edema Following Branch Retinal Vein Occlusion |
Santen Pharmaceutical Co., Ltd. |
PHASE2; PHASE3 | |
| NCT00576238 | COMPLETED | Atopic Eczema |
ACO Hud Nordic AB |
2004-01 | PHASE3 |
(data from https://clinicaltrials.gov, updated on 2026-06-01)
Check the
Betamethasone
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
Note: Technical data last updated: Sep 1, 2026.